We are live on ! Find out more
ULBI icon

Ultralife

54 hedge funds and large institutions have $34.3M invested in Ultralife in 2023 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 29 increasing their positions, 7 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

314% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 7

80% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 5

8% more funds holding

Funds holding: 5054 (+4)

1.84% more ownership

Funds ownership: 28.91%30.76% (+1.8%)

25% less capital invested

Capital invested by funds: $45.6M → $34.3M (-$11.3M)

73% less call options, than puts

Call options by funds: $7K | Put options by funds: $26K

Holders
54
Holders Change
+4
Holders Change %
+8%
% of All Funds
0.79%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
29
Reduced
7
Closed
5
Calls
$7K
Puts
$26K
Net Calls
-$19K
Net Calls Change
+$18K

ULBI Hedge Fund Activity: Q4 2023 in Review

54 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Ultralife (ULBI) for Q4 2023, worth a combined $34.3M — down 25% from $45.6M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new ULBI positions and 5 closed out — a net gain of 4 holders — while 29 added to existing stakes and 7 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $452K. The largest seller was EAM Investors, exiting entirely with an estimated $1.78M sold.

  • 54 institutional investors held Ultralife (ULBI) as of Q4 2023, up from 50 in Q3 2023.
  • Funds reported $34.3M of Ultralife stock for Q4 2023, down 25% quarter-over-quarter.
  • 9 funds opened new Ultralife positions in Q4 2023 and 5 closed out, a net change of +4 holders.
  • The largest Ultralife buyer in Q4 2023 was Renaissance Technologies, an estimated $452K added.
  • The largest Ultralife seller in Q4 2023 was EAM Investors, an estimated $1.78M sold.

Based on aggregated 13F filings for Q4 2023.